Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease
- PMID: 38835512
- PMCID: PMC11145452
- DOI: 10.1093/ckj/sfae140
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease
Abstract
Background: Albuminuria could potentially emerge as a novel marker of congestion in acute heart failure. However, the current evidence linking albuminuria and congestion in patients with congestive heart failure (CHF) remains somewhat scarce. This study aimed to evaluate the prevalence of albuminuria in a cohort of patients with CHF, identify the independent factors associated with albuminuria and analyse the correlation with different congestion parameters.
Methods: This is a subanalysis of the Spanish Cardiorenal Registry, in which we enrolled 864 outpatients with heart failure and a value of urinary albumin:creatinine ratio (UACR) at the first visit.
Results: The median age was 74 years, 549 (63.5%) were male and 438 (50.7%) had a reduced left ventricular ejection fraction. A total of 350 patients (40.5%) had albuminuria. Among these patients, 386 (33.1%) had a UACR of 30-300 mg/g and 64 (7.4%) had a UACR >300 mg/g. In order of importance, the independent variables associated with higher UACR were estimated glomerular filtration rate determined by the Chronic Kidney Disease Epidemiology Collaboration equation (R2 = 57.6%), systolic blood pressure (R2 = 21.1%), previous furosemide equivalent dose (FED; R2 = 7.5%), antigen carbohydrate 125 (CA125; R2 = 6.1%), diabetes mellitus (R2 = 5.6%) and oedema (R2 = 1.9%). The combined influence of oedema, elevated CA125 levels and the FED accounted for 15.5% of the model's variability.
Conclusions: In patients with chronic stable heart failure, the prevalence of albuminuria is high. The risk factors of albuminuria in this population are chronic kidney disease and hypertension. Congestion parameters are also associated with increased albuminuria.
Keywords: albuminuria; cardiorenal disease; congestion; congestive heart failure; predictors.
© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.
Conflict of interest statement
M.J.S. and J.N. are members of the CKJ editorial board.
Figures







Similar articles
-
Albuminuria as a marker of systemic congestion in patients with heart failure.Eur Heart J. 2023 Feb 1;44(5):368-380. doi: 10.1093/eurheartj/ehac528. Eur Heart J. 2023. PMID: 36148485 Free PMC article.
-
Albuminuria in chronic heart failure: prevalence and prognostic importance.Lancet. 2009 Aug 15;374(9689):543-50. doi: 10.1016/S0140-6736(09)61378-7. Lancet. 2009. PMID: 19683640
-
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.JACC Heart Fail. 2022 Nov;10(11):860-870. doi: 10.1016/j.jchf.2022.07.013. Epub 2022 Oct 12. JACC Heart Fail. 2022. PMID: 36328655 Clinical Trial.
-
Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk.J Clin Med. 2024 Jan 29;13(3):777. doi: 10.3390/jcm13030777. J Clin Med. 2024. PMID: 38337471 Free PMC article. Review.
-
Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry.Curr Heart Fail Rep. 2023 Jun;20(3):157-167. doi: 10.1007/s11897-023-00598-x. Epub 2023 May 24. Curr Heart Fail Rep. 2023. PMID: 37222949 Review.
References
-
- Kidney Disease: Improving Global Outcomes . CKD evaluation and management. https://kdigo.org/guidelines/ckd-evaluation-and-management/ [accessed 14 March 2021].
-
- Marcos MC, De La Espriella R, Ordás JG et al. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry. Rev Esp Cardiol (Engl Ed) 2024;77:50–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous